Follow
Nelson Hamerschlak
Nelson Hamerschlak
maria Flora e Israel Hamerschlak
Verified email at einstein.br
Title
Cited by
Cited by
Year
Dasatinib induces complete hematologic and cytogenetic responses in patients with imatinib-resistant or-intolerant chronic myeloid leukemia in blast crisis
J Cortes, P Rousselot, DW Kim, E Ritchie, N Hamerschlak, S Coutre, ...
Blood 109 (8), 3207-3213, 2007
5702007
Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia after failure of first-line imatinib: a randomized phase 2 trial
H Kantarjian, R Pasquini, N Hamerschlak, P Rousselot, J Holowiecki, ...
Blood, The Journal of the American Society of Hematology 109 (12), 5143-5150, 2007
5392007
Dasatinib or high‐dose imatinib for chronic‐phase chronic myeloid leukemia resistant to imatinib at a dose of 400 to 600 milligrams daily: two‐year follow‐up of a randomized …
H Kantarjian, R Pasquini, V Lévy, S Jootar, J Holowiecki, N Hamerschlak, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2009
2962009
Long-term outcomes after autologous hematopoietic stem cell transplantation for multiple sclerosis
PA Muraro, M Pasquini, HL Atkins, JD Bowen, D Farge, A Fassas, ...
JAMA neurology 74 (4), 459-469, 2017
2622017
Efficacy and safety of dasatinib in imatinib-resistant or-intolerant patients with chronic myeloid leukemia in blast phase
J Cortes, DW Kim, E Raffoux, G Martinelli, E Ritchie, L Roy, S Coutre, ...
Leukemia 22 (12), 2176-2183, 2008
2532008
Improvement in the outcome of invasive fusariosis in the last decade
M Nucci, KA Marr, M Vehreschild, C De Souza, E Velasco, P Cappellano, ...
Clinical Microbiology and Infection 20 (6), 580-585, 2014
1902014
BCL-2 as therapeutic target for hematological malignancies
GF Perini, GN Ribeiro, JV Pinto Neto, LT Campos, N Hamerschlak
Journal of hematology & oncology 11, 1-15, 2018
1792018
Haploidentical BMT and post-transplant Cy for severe aplastic anemia: a multicenter retrospective study
I Esteves, C Bonfim, R Pasquini, V Funke, NF Pereira, V Rocha, Y Novis, ...
Bone marrow transplantation 50 (5), 685-689, 2015
1672015
História da hemoterapia no Brasil
PC Junqueira, J Rosenblit, N Hamerschlak
Revista Brasileira de Hematologia e Hemoterapia 27, 201-207, 2005
1522005
Mesenchymal stromal cell infusion to treat steroid-refractory acute GvHD III/IV after hematopoietic stem cell transplantation
GM Dotoli, GC De Santis, MD Orellana, K de Lima Prata, SR Caruso, ...
Bone marrow transplantation 52 (6), 859-862, 2017
1112017
Randomized phase III study of alisertib or investigator’s choice (selected single agent) in patients with relapsed or refractory peripheral T-cell lymphoma
OA O’Connor, M Özcan, ED Jacobsen, JM Roncero, J Trotman, J Demeter, ...
Journal of Clinical Oncology 37 (8), 613, 2019
1102019
Brazilian experience with two conditioning regimens in patients with multiple sclerosis: BEAM/horse ATG and CY/rabbit ATG
N Hamerschlak, M Rodrigues, DA Moraes, MC Oliveira, ABPL Stracieri, ...
Bone marrow transplantation 45 (2), 239-248, 2010
1092010
Myeloablative reduced-toxicity iv busulfan-fludarabine and allogeneic hematopoietic stem cell transplant for patients with acute myeloid leukemia or myelodysplastic syndrome in …
G Alatrash, M De Lima, N Hamerschlak, M Pelosini, X Wang, L Xiao, ...
Biology of Blood and Marrow Transplantation 17 (10), 1490-1496, 2011
1052011
Incidence and risk factors of aplastic anemia in Latin American countries: the LATIN case-control study
E Maluf, N Hamerschlak, AB Cavalcanti, ÁA Júnior, J Eluf-Neto, ...
Haematologica 94 (9), 1220, 2009
1012009
Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6 blockade–refractory idiopathic multicentric Castleman disease
DC Fajgenbaum, RA Langan, AS Japp, HL Partridge, SK Pierson, ...
The Journal of clinical investigation 129 (10), 4451-4463, 2019
992019
Salivary SARS-CoV-2 load reduction with mouthwash use: A randomized pilot clinical trial
F de Paula Eduardo, L Corręa, D Heller, CA Daep, C Benitez, Z Malheiros, ...
Heliyon 7 (6), 2021
982021
Cost‐effectiveness of the introduction of specialized oral care with laser therapy in hematopoietic stem cell transplantation
LM Bezinelli, F de Paula Eduardo, RM da Graça Lopes, MGH Biazevic, ...
Hematological oncology 32 (1), 31-39, 2014
932014
Rituximab in refractory autoimmune diseases: Brazilian experience with 29 patients (2002-2004)
M Scheinberg, N Hamerschlak, JM Kutner, AAF Ribeiro, E Ferreira, ...
Clinical and experimental rheumatology 24 (1), 65, 2006
842006
Transplantation for autoimmune diseases in north and South America: a report of the Center for International Blood and Marrow Transplant Research
MC Pasquini, J Voltarelli, HL Atkins, N Hamerschlak, X Zhong, KW Ahn, ...
Biology of Blood and Marrow Transplantation 18 (10), 1471-1478, 2012
832012
Evaluation of three methods for hemoglobin measurement in a blood donor setting
J Rosenblit, CR Abreu, LN Szterling, JM Kutner, N Hamerschlak, ...
Sao Paulo medical journal 117, 108-112, 1999
801999
The system can't perform the operation now. Try again later.
Articles 1–20